MYD88 and diffuse large B-cell lymphoma: In 39 % of ABC-DLBCL cases, constitutive activation of NF-κB-dependent gene expression is activated by somatic, gain-of-function mutations in the myeloid differentiation primary response gene (88) (MyD88) [103].